P2.13-40 ABP 215 and Bevacizumab in NSCLC Patients: Time Course and Magnitude of Response in the Phase 3 Comparative Trial (MAPLE)

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	10
DOIs	https://doi.org/10.1016/J.JTHO.2018.08.1435
State	Published - Oct 1 2018
Externally published	Yes

Disciplines

@article{ff2c15b54178460880cdc21866d30fbc,

title = "P2.13-40 ABP 215 and Bevacizumab in NSCLC Patients: Time Course and Magnitude of Response in the Phase 3 Comparative Trial (MAPLE)",

author = "N. Thatcher and J. Goldschmidt and M. Thomas and M. Schenker and Z. Pan and V. Hanes",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/J.JTHO.2018.08.1435",

language = "American English",

volume = "13",

journal = "Journal of Thoracic Oncology",

number = "10",

}

TY - JOUR

T1 - P2.13-40 ABP 215 and Bevacizumab in NSCLC Patients: Time Course and Magnitude of Response in the Phase 3 Comparative Trial (MAPLE)

AU - Thatcher, N.

AU - Goldschmidt, J.

AU - Thomas, M.

AU - Schenker, M.

AU - Pan, Z.

AU - Hanes, V.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://christie.openrepository.com/handle/10541/621483

U2 - 10.1016/J.JTHO.2018.08.1435

DO - 10.1016/J.JTHO.2018.08.1435

M3 - Article

VL - 13

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -